Help improve the blood transfusion experience for MDS patients

Depending on blood transfusion has a negative impact on the quality of life of MDS patients, but it is unavoidable for many patients. That is the reason why a group of Canadian and United Kingdom haematologists are looking into running a series of studies to improve the red blood cell transfusion experience for MDS patients […]

Read full story

When is the right time to give a blood transfusion?

When the blood lacks enough healthy red blood cells or haemoglobin, anemia symptoms develop, typically fatigue, shortness of breath, weight loss, paler than normal skin, etc and a blood transfusion is considered. There is no set haemoglobin level at which a blood transfusion is given, but your doctor will assess your symptoms and you will […]

Read full story

The RIGHT treatment for the right patient at the right time – a crucial EU initiative

More than 70 participants representing medical specialists and nurses caring for MDS patients, MDS patient advocates, medical researchers and data managers, healthcare authorities, regulators, HTA experts and industry representatives gathered for the first MDS-RIGHT multi-stakeholder meeting on the 3 May 2017 in Valencia, Spain – in conjunction with the biannual MDS 2017 International Symposium. This project […]

Read full story

Can Azacitidine be administered at home? The Spanish experience

A new project was trialled for more than two years by nurses from home-care units in Spain: ‘Azacitidine (Vidaza) administration at home’. Now it has been rolled out to include most of the hospitals in Spain administering Azacitidine. It was initially undertaken by nurses, not necessarily haematology nurses, who would visit patients at home usually by taxi […]

Read full story

Realising the potential of haematology nurses and allied health professionals

The Haematology Institute Nurses and Allied health Professionals Group is hosting a one day event on 10th July 2017 at the Robens Suite, 29th floor, Tower Wing, Guy’s Hospital London SE1 9RT. The conference will celebrate the current contribution of nursing to the care of patients experiencing haematology disorders. With presentations from notable speakers and leaders […]

Read full story

Revlimid / Lenalidomide for MDS Patients: access in the UK

Are Revlimid and Lenalidomide the same drug? Yes, they are the same drug. Lenalidomide is the active substance in Revlimid. What is Revlimid? Lenalidomide is an immunomodulating agent, which operates on the immune system (the body’s natural defences). It works in a number of different ways: it blocks the development of abnormal cells, prevents the […]

Read full story

MDS Treatment: What to Expect from a Visit to a Consultant

Dr. Christopher Dalley & Dr. Timothy Chevassut – Haematologists at Brighton and Sussex University Hospitals Trust and Royal Sussex Hospital NHS Trust – give an account of how they discuss diagnosis and treatment with their MDS patients. Watch the video and read the transcript below.

Read full story
Free donations by shopping